Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2024

01-04-2024 | Rabeprazole | News item

PPI-related acute tubulointerstitial nephritis

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

The South African Health Products Regulatory Authority has alerted healthcare professionals of the risk of acute tubulointerstitial nephritis (TIN) associated with use of proton pump inhibitors (PPIs) including dexlansoprazole, esomeprazole, pantoprazole and rabeprazole, reports WHO in the WHO Pharmaceuticals Newsletter. …
Literature
Metadata
Title
PPI-related acute tubulointerstitial nephritis
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57099-9

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Cobimetinib

Case report

Multiple drugs

Case report

Cotrimoxazole

Case report

Cefalotin/dicloxacillin

Case report

COVID-19-vaccine-Gamaleya-National-Research-Center-of-Epidemiology-and-Microbiology

Case report

Multiple drugs